Navigation Links
Dr. Brian Mehling Talks Stem Cells at China's Taishan Academic Forum
Date:11/26/2013

NEW YORK, Nov. 26, 2013 /PRNewswire/ -- Dr. Brian Mehling, New York-based orthopedic surgeon and founder of Blue Horizon International, spoke Sunday in Shangdong, China at the 2013 Taishan Academic Forum International Conference on Hematopoietic Stem Cells and Leukemia.

Over 200 Chinese doctors and graduate students also attended the Taishan Academic Forum 2013 International Conference, sponsored by the Weifang Medical University in Shangdong.  They discussed the use of stem cell treatments for chronic conditions and acute diseases, and how such treatments have changed the face of global health care, allopathic medicines and traditional Chinese medicines.

"Stem cell treatments are without a doubt the future of medicine," stated Dr. Mehling.  "It is very important that young doctors learn about the possibilities in stem cell research, and also about the treatments that are already available for patients with different chronic conditions.

Blue Horizon International is a health care consulting company which combines cutting edge medical treatment and research with philanthropy.  BHI provides resources and services to children and adults of all backgrounds, but especially those who are medically underserved.  BHI subsidiaries have successfully performed over 2000 documented stem cell procedures on over 500 patients to date.  For more information please visit Blue Horizon International at www.bluehorizoninternational.com.

Media Contact:
Odd Einer
+1-212-206-0902

PRLog ID: www.prlog.org/12247276


'/>"/>
SOURCE Blue Horizon International
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Proove Biosciences CEO Brian Meshkin Wins 2013 Bridging the Gap Award by the Greater Baltimore Committee
2. Proove CEO and Vice Chairman of the Howard County Board of Education, Brian Meshkin, Selected as one of Howard County's Finest Under 39 by the Cystic Fibrosis Foundation
3. Verenium Announces Appointment Of Brian Carter As Vice President Of Grain Processing
4. Brian Cousins Joins Opedix Joint Support Athletic Wear as Vice President of Business Development
5. Shark Branding Corp. CEO Daymond John and Fuse Science CEO Brian Tuffin to be interviewed on Bloomberg Televisions "Taking Stock with Pimm Fox"
6. Brain Research Foundation 2013 Scientific Innovations Awards To Dr. Jean Hebert and Dr. Brian Litt
7. Pharmacovigilance Benefit-Risk Assessments: Requirements, Transparency, and Implications, a New and Upcoming Drug Safety Webinar Hosted by Xtalks
8. Respiratory Update: Interpreting Minimal Clinically Important Differences in COPD and Demonstrating Product Value with PROs, a New Life Science webinar Hosted by Xtalks
9. Pharmacovigilance: ADR Management and Reporting & Outsourcing Trends, A New Drug Safety Webinar from Xtalks
10. Data-driven Site Negotiations: Fast Track to Fair Market Value (FMV), a New Clinical Trials Webinar from Xtalks
11. Market Access and Pipeline Development – How Healthcare Modeling Can Make a Difference, a Pharmaceutical Market Strategy Webinar from Xtalks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... Jan. 17, 2017  Protagonist Therapeutics, Inc. (NASDAQ: ... has initiated a global Phase 2b induction study ... that targets alpha4beta7 integrin. The aim of this ... evaluate the safety/tolerability and efficacy of PTG-100 in ... to severe active disease. "We ...
(Date:1/16/2017)... , Jan. 16, 2017   Valentin A. Pavlov, ... MD , president and CEO of The Feinstein ... an analysis of how the nervous system regulates the ... develop bioelectronic medicine devices to treat disease ... Nature Neuroscience . The paper examines various ...
(Date:1/14/2017)... ... January 14, 2017 , ... Seattle-based Phase ... end-to-end genome assemblies to researchers around the globe. Long considered a “holy ... answering a wide range of scientific questions. The announcement was made today ...
(Date:1/13/2017)... Research and Markets has announced the addition of the "Global Biopolymers ... ... of 16.83% during the period 2017-2021. The report covers ... for 2017-2021. To calculate the market size, the report considers the revenue ... includes a a discussion of the key vendors operating in this market. ...
Breaking Biology Technology:
(Date:12/15/2016)... FREMONT, Calif. , Dec. 15, 2016   ... a publicly held genomics technology company, announced today that ... the Listing Qualifications Department of The Nasdaq Stock Market ... the closing bid price of WaferGen,s common stock had ... days.  Accordingly, WaferGen has regained compliance with Listing Rule ...
(Date:12/15/2016)... LONDON , Dec. 15, 2016 /PRNewswire/ ... the driving experience, health wellness and wellbeing ... As one in three new passenger vehicles ... voice recognition, gesture recognition, heart beat monitoring, ... eyelid monitoring, facial monitoring, and pulse detection. ...
(Date:12/15/2016)... "Increase in mobile transactions is driving the growth of ... expected to grow from USD 4.03 billion in 2015 ... of 29.3% between 2016 and 2022. The market is ... smart devices, government initiatives, and increasing penetration of e-commerce ... to grow at a high rate during the forecast ...
Breaking Biology News(10 mins):